Reading Roadmap943-P: A Retrospective Analysis of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and its Relation to PolycythemiaKey TakeawaysIntroduction: ...

Reading RoadmapRenal Effects of Canagliflozin in Type 2 Diabetes Patients: Insights from the INTENSIFY StudyKey TakeawaysIntroduction: Unraveling the Renal ...

Reading RoadmapCorrelation Between SGLT2i Duration and Urinary and Genitourinary Tract Infections in Type 2 Diabetes Patients: A Comprehensive Study Across ...

Reading RoadmapComparative Analysis of Enavogliflozin and Dapagliflozin Efficacy in Type 2 Diabetes Treatment Based on Renal Function: Results from Two ...

Reading Roadmap93-OR: Proliferation of Islet Reactive CD4 T-Cells and Early Disease Progression in Type 1 DiabetesKey TakeawaysIntroduction: Unraveling the ...

Reading Roadmap939-P: Evaluating the Safety of Recent Glucose Drugs in Adults with Type 2 Diabetes and Mild to Moderate Cardiovascular RiskKey ...

Reading RoadmapComparative Efficacy and Safety of SGLT2i and Other Oral Antidiabetic Drugs as Supplementary Therapy to Metformin in Type 2 Diabetes: A ...

Reading Roadmap936-P: Impact of SGLT2i and Pioglitazone on FIB-4 Index in Indian Patients with Metabolic Dysfunction Related Steatotic Liver Disease: A Real ...

Reading Roadmap196-OR: Utilizing Scalable AI to Revolutionize Type 2 Diabetes Management in Clinical SettingsKey TakeawaysIntroduction: The Intersection of AI ...

Reading Roadmap1969-LB: Early Postpartum Glucose Intolerance and Insulin Deficiency in WomenKey TakeawaysIntroduction: Unraveling the Complexities of ...

Reading RoadmapCorrelation Between Time Below Range and Level 2 Hypoglycemia Rates in Type 1 Diabetes: Findings from DCLP3, DIAMOND, and WISDM TrialsKey ...

Reading RoadmapHyperglycemia Triggers Increased Lactate Production in the Hypothalamus: An In-depth Analysis of Study 1776-LBKey TakeawaysIntroduction: ...

Reading Roadmap1635-P: Weight Loss from Survodutide Linked to Altered Food Choices and Dyslipidemia Improvement in Obese Hamsters Fed a Free Choice DietKey ...

Reading Roadmap1634-P: Unraveling the Changes in Bile Acid Circulation in Type 2 Diabetic Rats Post Sleeve GastrectomyKey TakeawaysIntroduction: A New ...

Reading Roadmap1633-P: Adipocytes Secrete CRISPLD2, Capable of Reducing Adipocyte SizeKey TakeawaysIntroduction: Unveiling the Secret of AdipocytesThe Role of ...

Reading Roadmap1632-P: Unveiling New Horizons in NASH Research through Wild-Derived Chromosome 1 Substitution StrainsKey TakeawaysIntroduction: A New Frontier ...

Reading Roadmap1631-P: A Revolutionary Approach to Combating Obesity through Enhanced Adipose Tissue ThermogenesisKey TakeawaysIntroduction: A New Frontier in ...

Reading Roadmap1630-P: Exploring the Therapeutic Possibilities of Olfactory Receptor OR51T1 in Treating ObesityKey TakeawaysIntroduction: A New Frontier in ...

Reading Roadmap162-OR: Metabolic Dysfunction Linked to Prolonged TNF-a Transcription in Obesity via H3K9/K18 AcetylationKey TakeawaysIntroduction: Unraveling ...

Reading Roadmap1629-P: STING Disruption's Protective Effect on Obesity-Related Liver Disease and Insulin Resistance Nullified by Seven-Month High Fat DietKey ...

Reading Roadmap1628-P: STAT1 Deletion in T-Cells Reduces Obesity and Enhances Insulin Sensitivity in Aging MiceKey TakeawaysIntroduction: Unraveling the Role ...

Reading RoadmapNovel Compound 1627-P: A Potential Solution for Obesity and Associated Metabolic Disorders Identified through High-Throughput ScreeningKey ...

Reading Roadmap1626-P: Harnessing ARO-INHBE, an siRNA Therapeutic, for Liver-Specific Suppression of INHBE in Metabolic Diseases TreatmentKey ...

Reading RoadmapGS-4571: A Revolutionary Oral GLP-1R Agonist for Diabetes ManagementKey TakeawaysIntroduction: A New Hope in Diabetes TreatmentUnderstanding ...

Reading Roadmap1624-P: Comparing the Impact of Postoperative Adult Growth Hormone Deficiency and Type 2 Diabetes on Fatty Liver DevelopmentKey ...

Reading Roadmap1623-P: Harnessing the Power of QuPath Artificial Intelligence for Pancreatic Cell CategorizationKey TakeawaysIntroduction: The Intersection of ...

Reading Roadmap1622-P: Correlation Between Lab Results and Histopathologic Reports of Acute Pancreatitis in nPOD Organ DonorsKey TakeawaysIntroduction: ...

Reading Roadmap1261-P: Does Elevated A1C in Elderly Adults with Cognitive and Functional Impairment Provide Sufficient Hypoglycemia Protection?Key ...

Reading RoadmapPredicting the Impact of Cardiometabolic Diseases on Health Disparities Among Middle-Aged Adults in the U.S.: A Microsimulation StudyKey ...

Reading Roadmap125-OR: Identifying New Lipid Biomarkers for Deteriorating Glucose Tolerance in Non-Diabetic Kin of Type 2 Diabetes PatientsKey ...

Reading Roadmap1259-P: Unraveling the Link Between Multiple Risk Factors and Functional Disability in Individuals With and Without Diabetes MellitusKey ...

Reading Roadmap1205-P: Analysis of Exocrine Function in Individuals Prone to Type 1 DiabetesKey TakeawaysIntroduction: Unraveling the ConnectionExocrine ...

Reading Roadmap1060-P: Enhanced Blood Sugar Regulation and Diabetes Self-Care for Pregnant Patients in Underserved CommunitiesKey TakeawaysIntroduction: The ...

Reading RoadmapEvaluating the Cost-Benefit of RSVpreF3 Vaccine with Adjuvant for Diabetic Adults Aged 50-59 in the USKey TakeawaysIntroduction: The Potential ...

Reading Roadmap1044-P: EHR's Best Practice Advisory Alert Minimizes Hypoglycemia from Insulin Administration in Actual Hospital EnvironmentKey ...

Reading Roadmap1029-P: Understanding Diabetic Complication Risk through Analysis of Freestyle Libre's Raw DataKey TakeawaysIntroduction: The Power of Data in ...

Reading Roadmap1016-P: Creating a Highly Precise HPLC Method for Measuring Salivary Glycated AlbuminKey TakeawaysIntroduction: The Promise of Salivary Glycated ...

Reading Roadmap1007-P: Sustained Glycemic Outcome Improvements in Level2 Members after Two YearsKey TakeawaysIntroduction: The Power of Digital Health ...

Reading RoadmapPatient Satisfaction and Time in Range Outcomes after 16 Weeks of iGlarLixi Treatment in Insulin-Naive Adults with Poorly Controlled Type 2 ...

Reading Roadmap838-P: The Effect of Age on the Performance and Safety of Weekly Insulin Icodec Versus Daily Insulin for Type 2 Diabetes (ONWARDS 1-5)Key ...

Reading Roadmap837-P: Enhanced Glycemic Control in Pediatric Type 1 Diabetes Patients through Closed-Loop Insulin Delivery: A Systematic ReviewKey ...

Reading Roadmap836-P: Compliance with App-Guided Dosage for Weekly Insulin Icodec in Insulin-Newbie Type 2 Diabetes - A Post Hoc Review of ONWARDS 5Key ...

Reading Roadmap835-P: Unconventional Pancreatogenic Diabetes - Treatment Experiences of Patients Post-PancreatectomyKey TakeawaysIntroduction: Understanding ...

Reading Roadmap834-P: An Examination of Transitioning from Basal Insulin to Insulin Degludec/Insulin Aspart in Type 2 Diabetes Patients with Lower FPG Levels ...

Reading Roadmap833-P: Global Survey Reveals Attitudes and Insights about Basal Insulin from People with Type 2 DiabetesKey TakeawaysIntroduction: Unveiling the ...

Reading Roadmap832-P: Desired Characteristics of Weekly Insulin by Individuals with Type 2 DiabetesKey TakeawaysIntroduction: The Potential of Weekly ...

Reading Roadmap831-P: Desired Features of Weekly Insulin by Individuals with Type 1 DiabetesKey TakeawaysIntroduction: The Potential of Weekly InsulinImproved ...

Reading Roadmap830-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 2 Diabetes—ONWARDS 1–5Key ...

Reading RoadmapCorrelation of Diabetic Complications and Comorbidities with Major Cardiovascular Events in Type 2 Diabetes: A Danish Registry-Based ...

Reading RoadmapComparative Study on Glycemic Results: Rapid Insulin vs Ultrarapid Insulin in Omnipod 5 (OP5)Key TakeawaysIntroduction: The Battle of Insulins ...

Reading Roadmap827-P: Efficacy and Security of Human Insulin Therapy in Aged Type 2 Diabetes PatientsKey TakeawaysIntroduction: The Role of Insulin Therapy in ...

Reading RoadmapComparative Study on the Efficacy and Safety of Once-Weekly Insulin Icodec and Once-Daily Basal Insulin in Type 2 Diabetes Patients Based on ...

Reading Roadmap825-P: Analysis of Insulin Efsitora Alfa (Efsitora) Pharmacokinetics Following Subcutaneous Administration at Various Injection LocationsKey ...

Reading Roadmap824-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 1 Diabetes—ONWARDS 6Key ...

Reading Roadmap823-P: Understanding the Molecular and Pharmacological Characteristics of GZR4, a Weekly Insulin AnalogKey TakeawaysIntroduction: A New Frontier ...

Reading Roadmap822-P: Comparing the Impact of NNC-965 and Insulin Glargine (IGla) on Heart Structure and FunctionKey TakeawaysIntroduction: The Role of NNC-965 ...

Reading Roadmap821-P: Cross-Sectional Study Comparing In-Hospital Glucose Management in Type 2 Diabetes Patients: AI Chatbot vs. PhysiciansKey ...

Reading RoadmapComparison of Faster-Acting Insulin Aspart and Insulin Aspart in Adults with Type 1 Diabetes Using Insulin Pump and Continuous Glucose ...

Reading Roadmap81-OR: Evaluating Different Screening Methods for Advanced Fibrosis from MASLD in Diabetic PatientsKey TakeawaysIntroduction: The Importance of ...

Reading Roadmap819-P: Introducing GZR101, A New Premix Insulin for Diabetes ControlKey TakeawaysIntroduction: A New Era in Diabetes ManagementThe Innovation of ...

Reading Roadmap818-P: Comparing the Impact of Insulin Efsitora Alfa and Glargine on Hypoglycemia Frequency and Severity under High-Risk Conditions in Type 2 ...

Reading Roadmap817-P: Comparative Analysis of Demographic, Clinical, and Treatment Traits in Patients with Prompt vs. Postponed Basal Insulin InitiationKey ...

Reading Roadmap816-P: Comparing Health Care Resource Use and Expenses Between Timely and Delayed Initiation of Basal InsulinKey TakeawaysIntroduction: The ...

Reading Roadmap815-P: Evaluating the Effectiveness of Identified Predictors for Over 15% Body Weight Reduction using Tirzepatide in Type 2 Diabetes Patients in ...

Reading Roadmap814-P: Identifying Early Selection Indicators of GLP-1 Receptor Agonists in Real-World Data for Japanese Type 2 Diabetes PatientsKey ...

Reading Roadmap813-P: Effective Application of Hybrid Closed Loop Insulin Pumps and GLP1 Agonists in Managing Diabulimia and Eating Disorders in Type 1 ...

Reading Roadmap812-P: Evaluating the Safety and Effectiveness of Early GLP1RA and SGLT2 Inhibitors Use in Post-Kidney Transplant Patients with Type 2 ...

Reading Roadmap811-P: Evaluating the Safety and Efficacy of iGlarLixi for Type 2 Diabetes Patients in South KoreaKey TakeawaysIntroduction: The Rising ...

Reading RoadmapThe Impact of Glucagon-Like-Peptide-1 Agonists on Overweight/Obese Adults with Type 1 Diabetes: A Retrospective Study from Saudi Arabia, 2023Key ...

Reading RoadmapThe Link Between Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiovascular Disease: A Study on Mortality Rates in Type 2 Diabetes ...

Reading Roadmap12-Month Follow-Up Study on Oral Semaglutide Treatment in Indian Patients with Type 2 Diabetes Mellitus (SOLID 809-P)Key TakeawaysIntroduction: ...

Reading Roadmap808-P: The Effect of Fasting on Compliance with Dosing Guidelines and Effectiveness of Oral Semaglutide in Type 2 Diabetes Patients during ...

Reading Roadmap807-P: The Impact of GLP-1 Agonists on Delayed Gastric Emptying During Elective Eye SurgeriesKey TakeawaysIntroduction: Unveiling the Impact of ...

Reading Roadmap806-P: Efficacy of a Combined Weight Reduction Program for Obesity and Prediabetes with the Use of GLP-1 DrugsKey TakeawaysIntroduction: The ...

Reading RoadmapInvestigating the Development, Physicochemical and Pharmacokinetic Properties of IVL3021, a Long-Acting Injectable Releasing SemaglutideKey ...

Reading RoadmapUnderstanding the Off-Label Use of GLP-1 Agonists by Providers in the T1D Exchange Quality Improvement CollaborativeKey TakeawaysIntroduction: ...

Reading Roadmap803-P: The Impact of Oral Semaglutide-Induced Weight Loss on Blood Sugar Regulation in Practical ScenariosKey TakeawaysIntroduction: Unveiling ...

Reading Roadmap802-P: Tirzepatide vs Basal Insulin: A Meta-analysis Study on Efficacy and Safety in Uncontrolled Diabetes Mellitus TreatmentKey ...

Reading Roadmap801-P: Understanding Teen Obesity and GLP-1 Receptor Agonists: A Comprehensive Review, Meta-analysis, and Network Meta-analysis of DrugsKey ...

Reading RoadmapPhase III Study Analysis: Comparing Liraglutide Biosimilar and Reference Biologic in Obese Type 2 Diabetes Mellitus Patients in IndiaKey ...

Reading Roadmap7-PUB: Pioneering Student Initiative Tackles Health Care Disparities in South Carolina's Free Medical ClinicsKey TakeawaysIntroduction: A Beacon ...

Reading RoadmapExploring the Link Between Glyoxalase 1 Expression and Kidney Disease in Type 1 Diabetes: A Causal StudyKey TakeawaysIntroduction: Unraveling ...

Reading RoadmapAutomated Insulin Adjustment in Type 1 Diabetes: A Randomized Controlled Trial of the 79-OR Decision Support SystemKey TakeawaysIntroduction: ...

Reading RoadmapThe Protective Effects of New Long-Lasting Triple Agonist, HM15275, on Kidney Health in Preclinical Models of Acute and Chronic Kidney ...

Reading Roadmap798-P: Unveiling the Potential Cardioprotective Effects of HM15275, a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, in Hypertension Animal ...

Reading Roadmap797-P: Comparative Multiomic Analysis of GLP1R Analogues Interaction NetworksKey TakeawaysIntroduction: Unraveling the Complexities of GLP1R ...

Reading RoadmapThe Impact of Glucose-Reducing Medications on COPD Flare-ups in Type 2 Diabetic AdultsKey TakeawaysIntroduction: Unraveling the ConnectionThe ...

Reading RoadmapEvaluating Tirzepatide's Impact on Lean Body Mass and Fat Mass BalanceKey TakeawaysIntroduction: Unveiling TirzepatideThe Impact of Tirzepatide ...

Reading Roadmap794-P: Impact of Liraglutide on Belly Fat Distribution and Sugar Metabolism in Chinese Obese PatientsKey TakeawaysIntroduction: The Obesity ...

Reading Roadmap793-P: Enhanced Efficacy of Biased GLP-1 Analog Ecnoglutide (XW003) Compared to Unbiased PeptidesKey TakeawaysIntroduction: The Promise of ...

Reading Roadmap792-P: A Revolutionary Gene Therapy for Type 2 DiabetesKey TakeawaysIntroduction: A New Hope for Type 2 DiabetesUnderstanding 792-P: The Science ...

Reading Roadmap791-P: How Age Influences the Reaction to Semaglutide Injections: Findings from the British Clinical Diabetologists' Audit ProgrammeKey ...

Reading Roadmap790-P: A Comparative Analysis of Tirzepatide and Placebo on BMI Category Shifts in Type 2 Diabetes Adults: A Post Hoc Analysis of the SURMOUNT-2 ...

Reading RoadmapMachine Learning Aided Pancreas MRI Segmentation: A 78-PUB StudyKey TakeawaysIntroduction: The Intersection of Machine Learning and Medical ...

Reading RoadmapCorrelation Between Breath Acetone and Capillary Beta Hydroxybutyrate in Type 1 Diabetes: A Study on 78-ORKey TakeawaysIntroduction: Unraveling ...

Reading Roadmap789-P: Unveiling a New, Extended-Effect Amylin Receptor Agonist for Weight ManagementKey TakeawaysIntroduction: A New Hope in the Fight Against ...

Reading Roadmap788-P: The Synergistic Impact of Ecnoglutide and Amylin Analogs on Weight Loss in Preclinical Animal StudiesKey TakeawaysIntroduction: Unveiling ...

Reading RoadmapStudy Protocol: The Impact of Semaglutide on Cardiometabolic Risk Reduction in Type 1 Diabetes - A Double-Blind, Randomized, Placebo-Controlled ...

Reading RoadmapEffectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in Type 2 Diabetes Patients Based on Initial BMI: A Real-Life StudyKey ...

Reading Roadmap785-P: Evaluating the Preclinical Safety, Pharmacokinetics, and Pharmacodynamics of a Sustained-Release, Once-Monthly Injectable Semaglutide ...